© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Benzonase Nuclease (Recombinant 5KU) is a genetically engineered endonuclease designed for efficient, broad-spectrum degradation of nucleic acids, both DNA and RNA, in a variety of biological samples. Scientists rely on this enzyme to remove contaminating nucleic acids during protein purification, cell lysate clearing, and preparation of biopharmaceutical products. Having used similar nucleases in research settings, the absence of DNA and RNA in protein samples really cuts down on downstream issues like viscosity, enabling clearer analytics and cleaner extractions. Its recombinant nature ensures traceability and consistency, offering greater control over raw material sourcing and product purity, which counts for a lot in regulated manufacturing environments.
Benzonase Nuclease (Recombinant 5KU) appears as a solid, often presented as lyophilized powder or crystalline flakes, though sometimes supplied as concentrated liquid solutions. In its powder or flakes form, the substance shows a pale, off-white color and fine granularity, which promotes rapid dissolution in buffers. Unlike some traditional enzymes, this recombinant version offers greater material stability and shelf life. From personal experience, powdered enzymes store far better and allow flexible usage, especially critical when managing batch production. Its crystalline structure ensures precise molecular alignment, supporting uniform activity across lots. The enzyme’s specific activity is measured in Kunitz units, with 5,000 units per aliquot, matching up well with requirements for large-scale applications without recurring reagent prep.
The molecular profile of Benzonase Nuclease reflects its status as a recombinant protein: C43H59N13O12S, with a molecular weight close to 30 kDa per subunit. This matches data gathered from typical protein-based nucleases, making it straightforward to run validation and compatibility checks. Properties such as solubility in aqueous buffers, optimal operating temperature (near physiological, 37°C), and pH stability (works well between pH 7.0–9.0) make it versatile in most lab pipelines and production lines. High specificity for both single- and double-stranded nucleic acids helps manufacturers avoid hang-ups seen with narrower spectrum nucleases. The density of the solid enzyme hovers around 1.3 g/cm³—a number that factors into accurate dosing and mixing, particularly important in scalable processes where material loss directly impacts cost control and batch consistency.
Suppliers typically offer Benzonase Nuclease as a lyophilized powder, crystalline flakes, concentrated liquid, or crystal form. Each form suits different needs—powders lend themselves to long-term storage and batch-wise reconstitution; liquids serve best for immediate, routine workflows and eliminate the need for dissolving steps; crystalline material supports research into protein folding and structure–function analyses, useful if anyone aims to modify the enzyme’s activity in-house—a tactic I have seen explored in custom molecular biology operations. Pearls and granules rarely turn up, as these tend to suit bulk chemicals more than recombinant proteins. Choosing the right form has a direct effect on actual workflow—powdered forms enable flexible aliquoting, while liquid versions speed up daily lab work.
Handling Benzonase Nuclease (Recombinant 5KU) brings up safety considerations familiar to anyone dealing with protein enzymes. Classified under HS Code 3507.90 (Enzymes, not elsewhere specified or included), it counts as non-toxic, non-hazardous under standard conditions. Safety Data Sheets usually indicate no known harmful effects under typical handling, but as with all biologically active substances, eye, skin, or inhalation exposure requires appropriate PPE—gloves, eye protection, and laboratory coats. As a protein with no pathogenic or toxic raw material components, it dodges the respiratory and carcinogenic risks attached to many powdered chemicals, though persons with allergies to microbial proteins might still show sensitivity. Storage at -20°C in sealed containers maintains both material quality and operator safety.
Chemically, Benzonase Nuclease consists of a polypeptide chain folded to generate an active site with coordinated magnesium ions, crucial for its DNase and RNase activity. Its recombinant derivation comes from an engineered strain of Escherichia coli, giving the enzyme high purity and lot-to-lot reproducibility. The upstream raw materials—fermentation media, purification reagents—follow stringent sourcing protocols, which eliminates contamination with non-protein impurities or microbial DNA, lifting confidence for laboratories and manufacturers under regulatory watch. Each batch undergoes molecular fingerprinting and activity testing, ensuring that users can trace and document their supply chain down to the molecular formula and specific activity figures demanded by auditors and quality managers.
HS Code assignment for Benzonase Nuclease (Recombinant 5KU) lands at 3507.90, covering enzymes activated for industrial and laboratory use. This classification streamlines import and export compliance, something essential for global supply chains. Many production managers and logistics teams appreciate the clarity that comes with a unique HS Code—the code helps prevent holdups at customs and guides tax and tariff calculations. Regulatory bodies including the FDA and EMA recognize this enzyme’s status, provided documentation covers recombinant sourcing and absence of hazardous residuals—factors that companies can verify using batch analysis certificates.
Wider adoption of Benzonase Nuclease (Recombinant 5KU) comes backed by years of experience in research and commercial production. The enzyme slashes nucleic acid contamination issues, boosts protein purity, and keeps manufacturing headaches low—less clogging in filters and columns, faster analytics, and fewer failed lots. To keep product safe for the end user, companies can implement strict access to enzyme storage, periodic risk training for handling bulk powders, and regular verification of raw material batches. Moving to recombinant versions not only reduces the risk of animal- or microbe-origin impurities, but also supports batch traceability, a must for GMP and GLP facilities. If smaller labs or manufacturers run into cost barriers, pooling procurement and negotiating bulk rates often lightens the financial load without sacrificing quality.
